Could this anti-aging dog pill lead to one for you too?

Short Wave

Every dog lover’s greatest fear is inevitably losing their pet to time. We want our furry pals to stick around as long as they can. That wish may soon become reality with a new pill from a company called Loyal. It aims to extend the lives–and health–of dogs. This new drug also serves as a pitstop on a much bigger quest: to eventually lengthen human lives.

Interested in more science about your pets? Email us your question at shortwave@npr.org.

Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy
More description
Every dog lover’s greatest fear is inevitably losing their pet to time. We want our furry pals to stick around as long as they can. That wish may soon become reality with a new pill from a company called Loyal. It aims to extend the lives–and health–of dogs. This new drug also serves as a pitstop on a much bigger quest: to eventually lengthen human lives.

Interested in more science about your pets? Email us your question at shortwave@npr.org.

Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy
2026-07-07 11 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.